myelofibrosis
Showing 76 - 100 of 170
Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)
Recruiting
- Myelofibrosis
- Jaktinib hydrochloride tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021
MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- (no location specified)
Nov 29, 2021
Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study
Active, not recruiting
- Myelofibrosis
-
Firenze, FI, Italy
- +5 more
Nov 11, 2021
Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)
Completed
- Hematological Disease
- +5 more
- Total Body Irradiation 1200 cGy
- +9 more
-
Rochester, New YorkWilmot Cancer Institute
Nov 1, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)
Withdrawn
- Acute Myeloid Leukemia
- +7 more
- MDG1021 dose 1
- +3 more
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Sep 30, 2021
Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)
Completed
- Myelofibrosis
- Imetelstat 4.7 mg/kg
- Imetelstat 9.4 mg/kg
-
Birmingham, Alabama
- +71 more
Aug 17, 2021
Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)
Completed
- Myelofibrosis
- A: Fludarabine + Busulphan
- B: Fludarabine + Thiotepa
-
Alessandria, Italy
- +20 more
Aug 19, 2021
Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)
Recruiting
- Primary Myelofibrosis, Prefibrotic Stage
- Myelofibrosis
- Ropeginterferon alfa-2b
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021
Myelofibrosis, Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)
Recruiting
- Myelofibrosis
- +3 more
- Jaktinib hydrochloride tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Jun 11, 2021
Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory
Active, not recruiting
- Acute Megakaryoblastic Leukemia
- +2 more
- Alisertib
- +2 more
-
Miami, Florida
- +2 more
May 4, 2021
Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)
Recruiting
- Cancer, Metastatic
- +42 more
- Clinical Trial Matching
-
New York, New YorkMassive Bio, Inc
May 21, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia Trial in Lebanon (drug, radiation, procedure)
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Cyclophosphamide
- +6 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center, Norris Cotton Cancer Center
Apr 29, 2021
Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk
Recruiting
- Myelofibrosis
- +2 more
- Hematopoietic stem cell transplant
- +2 more
-
Calgary, Alberta, Canada
- +4 more
Feb 16, 2021
Myelofibrosis Trial (Allogenic transplantation transplantation)
Not yet recruiting
- Myelofibrosis
- Allogenic transplantation transplantation
- (no location specified)
Jan 24, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Myelofibrosis Trial in Summit (Oral Fedratinib)
Available
- Myelofibrosis
- Oral Fedratinib
-
Summit, New JerseyCelgene
Sep 17, 2020
Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)
Terminated
- Myelofibrosis
-
Stanford, California
- +1 more
Aug 31, 2020
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)
Terminated
- Leukemia
- +3 more
- Rigosertib
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 5, 2020